Vivanza Biosciences Limited (VIVANZA.BO)
INR 2.2
(-1.35%)
INR 2.2
(-1.35%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 11.2 Million INR | 61.26% |
| 2022 | 11.37 Million INR | 888.34% |
| 2021 | 8.56 Million INR | -35.05% |
| 2020 | 2.88 Million INR | 132.43% |
| 2019 | 2.36 Million INR | -1580.69% |
| 2018 | -198.55 Thousand INR | -103.3% |
| 2017 | 143.05 Thousand INR | 299.06% |
| 2016 | 108.47 Thousand INR | -397.9% |
| 2015 | - INR | -111007.86% |
| 2014 | 1.00 INR | 97.84% |
| 2013 | -25 Thousand INR | 99.84% |
| 2012 | -15.98 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.11 Million INR | -69.29% |
| 2024 Q1 | 3.61 Million INR | 320.43% |
| 2023 Q4 | -1.34 Million INR | -146.34% |
| 2023 Q2 | 3.18 Million INR | -46.12% |
| 2023 Q3 | 2.91 Million INR | -8.63% |
| 2023 FY | - INR | 54.3% |
| 2023 Q1 | 5.91 Million INR | 15261.54% |
| 2022 Q4 | -39 Thousand INR | -100.7% |
| 2022 Q2 | 2.73 Million INR | 118.43% |
| 2022 FY | - INR | 888.34% |
| 2022 Q1 | 1.25 Million INR | 216.16% |
| 2022 Q3 | 5.6 Million INR | 104.94% |
| 2021 Q4 | -1.07 Million INR | -460.2% |
| 2021 Q1 | -442 Thousand INR | 41.92% |
| 2021 Q3 | 299 Thousand INR | -24.49% |
| 2021 FY | - INR | -35.05% |
| 2021 Q2 | 396 Thousand INR | 189.59% |
| 2020 Q4 | -761 Thousand INR | -131.47% |
| 2020 FY | - INR | 132.43% |
| 2020 Q1 | -69 Thousand INR | -105.7% |
| 2020 Q2 | 932.5 Thousand INR | 1451.45% |
| 2020 Q3 | 2.41 Million INR | 159.3% |
| 2019 Q4 | 1.21 Million INR | 210.66% |
| 2019 FY | - INR | -1580.69% |
| 2019 Q3 | -1.09 Million INR | 3.19% |
| 2019 Q2 | -1.13 Million INR | 12.27% |
| 2019 Q1 | -1.28 Million INR | -16.48% |
| 2018 Q3 | -1.16 Million INR | -17.29% |
| 2018 Q4 | -1.1 Million INR | 4.68% |
| 2018 Q2 | -989 Thousand INR | -6.23% |
| 2018 FY | - INR | -103.3% |
| 2018 Q1 | -931 Thousand INR | -2.29% |
| 2017 FY | - INR | 299.06% |
| 2017 Q3 | -1.04 Million INR | -16.7% |
| 2017 Q4 | -910.16 Thousand INR | 12.57% |
| 2017 Q1 | -856 Thousand INR | -150.37% |
| 2017 Q2 | -892 Thousand INR | -4.21% |
| 2016 Q1 | - INR | 100.0% |
| 2016 Q3 | -2 Million INR | -200499.9% |
| 2016 Q2 | -1000.00 INR | 0.0% |
| 2016 Q4 | -341.89 Thousand INR | 82.96% |
| 2016 FY | - INR | -397.9% |
| 2015 Q2 | - INR | 0.0% |
| 2015 Q4 | -563.00 INR | 0.0% |
| 2015 FY | - INR | -111007.86% |
| 2015 Q1 | - INR | 100.0% |
| 2015 Q3 | - INR | 0.0% |
| 2014 Q1 | - INR | 100.0% |
| 2014 Q3 | - INR | 0.0% |
| 2014 Q2 | - INR | 0.0% |
| 2014 FY | - INR | 97.84% |
| 2014 Q4 | -547.00 INR | 0.0% |
| 2013 Q3 | - INR | 0.0% |
| 2013 Q2 | - INR | 0.0% |
| 2013 Q1 | - INR | 100.0% |
| 2013 Q4 | -25.33 Thousand INR | 0.0% |
| 2013 FY | - INR | 99.84% |
| 2012 FY | - INR | 0.0% |
| 2012 Q4 | -14.76 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -1654.04% |
| Sastasundar Ventures Limited | -203.51 Million INR | 105.505% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | 3.28% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 87.413% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 86.698% |
| Sunil Healthcare Limited | 93.07 Million INR | 87.963% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | 32.171% |
| MedPlus Health Services Limited | 3.94 Billion INR | 99.716% |
| Zenith Healthcare Limited | 4.98 Million INR | -124.619% |
| Patidar Buildcon Limited | -5.52 Million INR | 302.751% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 87.207% |
| Roopa Industries Limited | 55.7 Million INR | 79.885% |
| Smruthi Organics Limited | 120.31 Million INR | 90.688% |
| Trident Lifeline Limited | 102.69 Million INR | 89.09% |
| Bacil Pharma Limited | -569.32 Thousand INR | 2067.962% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 109.088% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | 29.433% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 107.417% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 58.798% |
| PANJON LTD. | 4.08 Million INR | -174.003% |
| Tyche Industries Limited | 128.2 Million INR | 91.261% |
| Trimurthi Limited | -2.47 Million INR | 552.046% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 158.807% |
| Anuh Pharma Limited | 878.5 Million INR | 98.725% |
| Crestchem Limited | 30.33 Million INR | 63.065% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 203.568% |
| Zenlabs Ethica Limited | 27.09 Million INR | 58.651% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 97.104% |
| ANG Lifesciences India Limited | 90.66 Million INR | 87.642% |
| Parmax Pharma Limited | 22.93 Million INR | 51.154% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 97.12% |
| Deccan Health Care Limited | 37.5 Million INR | 70.127% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 94.827% |
| Norris Medicines Limited | -1.78 Million INR | 727.976% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 95.592% |
| Veerhealth Care Limited | 15.99 Million INR | 29.953% |
| Makers Laboratories Limited | 25.81 Million INR | 56.594% |
| Lactose (India) Limited | 201.22 Million INR | 94.432% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 111.65% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 93.432% |
| Mercury Laboratories Limited | 101.18 Million INR | 88.928% |
| Gennex Laboratories Limited | 219.35 Million INR | 94.892% |
| PRAVEG LIMITED | 321.43 Million INR | 96.514% |
| Denis Chem Lab Limited | 224.84 Million INR | 95.017% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 98.165% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 97.035% |
| Colinz Laboratories Limited | 5.42 Million INR | -106.411% |
| Godavari Drugs Limited | 134.62 Million INR | 91.678% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 2859.606% |
| Zenotech Laboratories Limited | 172.64 Million INR | 93.51% |
| Panchsheel Organics Limited | 189.36 Million INR | 94.083% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 97.503% |
| Phaarmasia Limited | -1.58 Million INR | 808.217% |
| Bharat Parenterals Limited | 265.74 Million INR | 95.784% |
| Medi-Caps Limited | 4.77 Million INR | -134.835% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 511.912% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 98.652% |
| BDH Industries Limited | 124.27 Million INR | 90.984% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 134.603% |
| Coral Laboratories Limited | 227.07 Million INR | 95.066% |
| Concord Drugs Limited | 40.52 Million INR | 72.349% |
| Beryl Drugs Limited | 26.63 Million INR | 57.941% |
| Evoq Remedies Limited | 6.18 Million INR | -81.061% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 86.438% |
| Transchem Limited | 56.61 Million INR | 80.209% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | 5.754% |
| Parnax Lab Limited | 243.59 Million INR | 95.401% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 74.993% |
| Kerala Ayurveda Limited | 70.78 Million INR | 84.172% |
| Cian Healthcare Limited | 122.56 Million INR | 90.859% |
| Trinity League India Limited | -26.25 Million INR | 142.677% |
| Syschem (India) Limited | 70.4 Million INR | 84.085% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 230.689% |
| Natural Capsules Limited | 219.9 Million INR | 94.905% |
| Auro Laboratories Limited | 121.73 Million INR | 90.796% |